Characterization of a Human Platelet Antigen-1a–Specific Monoclonal Antibody Derived from a B Cell from a Woman Alloimmunized in Pregnancy-Reference-Cited by-同舟云学术

Characterization of a Human Platelet Antigen-1a–Specific Monoclonal Antibody Derived from a B Cell from a Woman Alloimmunized in Pregnancy

Published:2015-05-13 Issue:12 Volume:194 Page:5751-5760
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Eksteen Mariana,Tiller Heidi,Averina Maria,Heide Gøril,Kjaer Mette,Ghevaert Cedric,Michaelsen Terje E.,Ihle Øistein,Husebekk Anne,Skogen Bjørn,Stuge Tor B.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.

2. Human platelet antigens - 2013

3. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.;Williamson;Blood,1998

4. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia

5. Tiller H. Kamphuis M. M. Flodmark O. Papadogiannakis N. David A. L. Sainio S. Koskinen S. Javela K. Wikman A. T. Kekomaki R. . 2013. Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry. BMJ Open 3.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention;Thrombosis and Haemostasis;2024-08-21

2. Generation of human antibodies targeting human platelet antigen (HPA)‐1a;Transfusion;2024-02-24

3. An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study;Journal of Thrombosis and Haemostasis;2023-04

4. A novel monoclonal antibody with improved FcγR blocking ability demonstrated non-inferior efficacy compared to IVIG in cynomolgus monkey ITP model at considerably lower dose;Clinical and Experimental Immunology;2022-12-08

5. Prophylactic administration of HPA-1a–specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice;Blood;2022-11-17